본문영역
-
Pharma
LG Chem partners with EuBiologics to develop pediatric vaccine against 6 diseases
LG Chem has announced a partnership with EuBiologics to enhance the domestic production capabilities of pediatric vaccines in Korea.The collaboration focuses on developing the hexa...
Lee Han-soo
2024-04-25 3:15 PM
-
Pharma
Entresto builds clinical evidence for 'heart failure with ejection fraction...
Novartis' angiotensin receptor-neprilysin inhibitor (ARNI) heart failure treatment Entresto (sacubitril/valsartan) has reduced hospitalization rates in patients with newly diagnose...
Kim Chan-hyuk
2024-04-25 2:48 PM
-
Device/ICT
Ybrain and Meditrix to collaborate on mind health digital devices
Ybrain said it has signed a memorandum of understanding (MOU) with Meditrix, a digital medical device company, to collaborate on developing a digital treatment device for depressio...
Yang Hyeon-su
2024-04-25 1:00 PM
-
Device/ICT
VUNO's AI-based ophthalmic diagnostic SW receives key regulatory approval
VUNO said its AI-based retinal imaging diagnostic support solution, VUNOMED Fundus AI, has received approval from the Ministry of Food and Drug Safety (MFDS) for an integrated revi...
Lee Han-soo
2024-04-25 1:02 PM
-
Device/ICT
Noul releases malaria diagnostics study result in Africa
Noul, an AI-based blood and cancer diagnostic platform company, said it presented the results of a clinical performance study of its malaria diagnostic solution at an African confe...
Yang Hyeon-su
2024-04-25 11:44 AM
-
Device/ICT
Macrogen breaks ground for ‘Asia’s largest genome big data hub’
Macrogen, a Korean digital healthcare company, said it held a groundbreaking ceremony for the Songdo Global Genome Center in Incheon. The company emphasizes that this facility is A...
Kim Yoon-mi
2024-04-25 10:32 AM
-
Pharma
Moderna, Yonsei University collaborate on mRNA education to foster experts
Moderna and the Korean National Institute for Bioprocessing Research and Training (K-NIBRT) at Yonsei University have signed an agreement to develop mRNA education content and prog...
Korea Biomedical Review
2024-04-25 11:04 AM
-
Device/ICT
Lunit to release 7 AI biomarker platform-based study abstracts at ASCO 2024
Medical AI company Lunit said Thursday that it would present seven research studies using its AI biomarker platform, “Lunit SCOPE,” at the 2024 American Society of Clinical Oncolog...
Korea Biomedical Review
2024-04-25 10:45 AM
-
Pharma
Jeil Pharma’s subsidiary receives approval for Korea’s 37th novel drug to treat GERD
Onconic Therapeutics, a subsidiary of Jeil Pharma Holdings, said it received approval from the Ministry of Food and Drug Safety for Jaqbo (ingredient: Zastaprazan), a drug for the ...
Lee Han-soo
2024-04-25 10:22 AM
-
Hospital
SNUH to suspend all treatments next Tuesday as senior doctors leave hospital
Professor Bang Jae-seung, chairman of the emergency committee of the Seoul National University College of Medicine and Seoul National University Hospital (SNUH) faculty council, wi...
Koh Jung Min
2024-04-24 3:37 PM
-
Pharma
Viatris celebrates Lipitor's vital role in dyslipidemia control, CVD prevention in Korea
Viatris Korea celebrated 25 years of Lipitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at ...
Lee Han-soo
2024-04-24 3:05 PM
-
Pharma
Fexuclue sales soar 57% in Q1, boosting Daewoong's GERD market growth
Daewoong Pharmaceutical said Thursday that Fexuclue's prescription sales grew 57 percent year over year to 17 billion won ($12.4 million) in the first quarter of this year.Accordin...
Yang Hyeon-su
2024-04-24 4:22 PM
-
Hospital
New research offers hope in multiple myeloma treatment through enhanced NK...
Severance Hospital researchers have identified a promising method to rejuvenate the effectiveness of natural killer cells in combating multiple myeloma, a serious form of blood can...
Lee Han-soo
2024-04-24 5:06 PM
-
Policy
RIGHT Foundation opens grants for global health equity in infectious disease
The Research Investment for Global Health Technology Foundation, commonly known as the RIGHT Foundation, said it opened its grant application aimed at significantly enhancing healt...
Lee Han-soo
2024-04-24 4:08 PM
-
Device/ICT
VUNO introduces cardiac arrest risk monitoring device at critical care society’s meet
VUNO will exhibit its AI-powered cardiac arrest risk monitoring device, VUNO Med-DeepCARS, at the 44th Korean Society of Critical Care Medicine (KSCCM) Annual Congress-Acute and Cr...
Yang Hyeon-su
2024-04-24 4:01 PM
-
Hospital
This pediatrician found greatest reward in children’s laughs but the government...
"We are very sorry that we will be unable to be by your side."That's what the Department of Pediatric Nephrology professors at Seoul National University Hospital (SNUH) wrote in a ...
Kim Ju-yeon
2024-04-24 1:46 PM
-
Pharma
Darzalex’s reimbursement has been in limbo for 3 years. Will it be different this time?
Attention is drawn to whether the reimbursement criteria for the multiple myeloma drug Darzalex (daratumumab), unchanged since May 2021, will be expanded for the first time in thre...
Kim Yun-mi
2024-04-24 11:38 AM
-
Pharma
Chong Kun Dang signs licensing deal for Curigin's bladder cancer gene therapy
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial b...
Lee Han-soo
2024-04-24 1:47 PM
-
Hospital
Major hospitals in Seoul to protest government policy with weekly day off
Senior physicians at Seoul National University Hospital (SNUH) and Asan Medical Center (AMC) said they decided to refuse surgery and outpatient care by taking a day off every week ...
Kim Eun-young
2024-04-24 9:51 AM
-
Pharma
Hanmi Pharm partners with MSD for clinical trial of cancer therapy BH3120
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partn...
Lee Han-soo
2024-04-23 5:20 PM
-
Bio
Samsung Bioepis gains European approval for Stelara biosimilar
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referen...
Lee Han-soo
2024-04-23 4:04 PM
-
Device/ICT
Medical AI companies begin to supply homegrown solutions
AI solutions developed by Korean medical artificial intelligence companies, including Lunit, have begun to be used in medical sites, raising expectations among market players and t...
Kim Chan-hyuk
2024-04-23 12:43 PM
-
Policy
Despite government’s refusal to accept resignation, medical professors ‘quietly’...
A top government official recently said that professors at even private medical schools, let alone national ones, are subject to the National Civil Service Act, raising the possibi...
Kwak Sung-sun
2024-04-23 4:02 PM
-
Pharma
GC Biopharma applies for US approval of Sanfilippo Syndrome treatment
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (I...
Lee Han-soo
2024-04-23 3:02 PM
-
Pharma
Pharos iBio and MEDiC to collaborate on new drug research
Pharos iBio said it has signed a memorandum of understanding with MEDiC Life Sciences, a Silicon Valley-based company that has established a gene-scissor technology (CRISPR) based ...
Yang Hyeon-su
2024-04-23 4:54 PM
-
Pharma
Curocell applies for expedited approval of CAR-T therapy
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced ...
Lee Han-soo
2024-04-23 11:00 AM
-
Bio
Jung Kwan Jang hosts seminar on red ginseng at US conference
Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the S...
Lee Han-soo
2024-04-23 3:02 PM
-
Pharma
Celltrion's Remsima attains 74% market share in 5 key European countries
Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spa...
Korea Biomedical Review
2024-04-23 11:51 AM
-
Device/ICT
Kakao Healthcare and OURHOME to research and develop AI-based…
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions...
Korea Biomedical Review
2024-04-23 11:01 AM
-
Pharma
HK inno.N’s GERD drug K-CAB advances to Middle East, North Africa
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is...
Korea Biomedical Review
2024-04-23 11:50 AM
-
Device/ICT
Deep Bio's prostate cancer diagnosis software aims to enter US…
The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most c...
Lee Han-soo
2024-04-22 3:13 PM
-
Pharma
MBK Partners to buy pharma distributor Geo-Young for nearly ₩2 trillion: report
Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximat...
Lee Han-soo
2024-04-22 4:17 PM
-
Pharma
Palmoplantar pustulosis patients pin hope on Skyrizi’s approval
Skyrizi (risankizumab) has emerged as a new option for treating palmoplantar pustulosis (PPP), a condition characterized by pustules, exfoliation, and red patches on the palms of t...
Kim Chan-hyuk
2024-04-22 4:38 PM
-
Pharma
Bayer Korea launches plogging campaign to celebrate Earth Day
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices a...
Lee Han-soo
2024-04-22 5:01 PM
-
Device/ICT
Canon Medical installs AI-backed low-dose radiation CT simulation at Yeungnam...
Canon Medical Systems Korea said it installed Aquilion Exceed LB, a state-of-the-art low-dose radiation CT (computed tomography) simulation machine, at Yeungnam University Medical ...
Korea Biomedical Review
2024-04-22 2:42 PM
-
Device/ICT
Plasmapp to supply plasma sterilizer to Osstem Implant
Plasmapp, a bioplasma deep-tech company, said Monday that it had signed a contract to supply plasma sterilizers to Osstem Implant.Following signing contracts with large global dist...
Korea Biomedical Review
2024-04-22 2:57 PM
-
Device/ICT
Boston Scientific launches intragastric appetite suppression balloon 'BIB System' with coverage
Boston Scientific said Monday that it has released the BIB System, a balloon for suppressing appetite in the stomach that can help obese patients lose weight, with insurance covera...
Korea Biomedical Review
2024-04-22 3:20 PM
-
Hospital
‘Low-dose, off-label prescription of NOACs is a risky, misleading choice’
Atrial fibrillation (AF) is one of the most common arrhythmias, with a higher prevalence in older adults. It significantly increases the risk of stroke, and the number of patients ...
Kim Chan-hyuk
2024-04-22 1:45 PM
-
Pharma
Polycythemia vera moves a step closer to potential cure
Polycythemia vera (PV) is a rare, intractable blood cancer in which a somatic mutation in the bone marrow causes the bone marrow to function abnormally and overproduce red blood ce...
Kim Yun-mi
2024-04-22 1:05 PM
-
Pharma
EuBiologics wins green light for phase 1 trial of shingles vaccine
On Monday, EuBiologics announced that it obtained regulatory approval to initiate a phase 1 study for its proprietary herpes zoster vaccine, EuHZV. With the endorsement from the Mi...
Korea Biomedical Review
2024-04-22 1:31 PM
-
Policy
KPBMA head named to chair Korea's healthcare reform panel
The government has nominated Noh Yun-hong, head of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), to chair the presidential Special Committee for Health...
Kwak Sung-sun
2024-04-22 11:17 AM
-
Pharma
Regulator approves four generics of oral psoriasis treatment Otezla
Four Korean drugmakers have obtained approval for generic versions of Amgen's oral psoriasis treatment, Otezla (apremilast).Daewoong Pharmaceutical, DongKoo Bio&Pharma, Dong-A ST, ...
Yang Hyeon-su
2024-04-19 4:27 PM
-
Pharma
Pharma distributor Geo-Young's revenue hits ₩4.4 trillion in 2023
Pharmaceutical distribution company Geo-Young said Friday that its consolidated sales for 2023 reached 4.43 trillion won ($3.21 billion).It marked a 5 percent increase from the pre...
Yang Hyeon-su
2024-04-19 4:25 PM
-
Policy
Covid-19 crisis to be downgraded to lowest 'attention' level starting in May
The Covid-19 crisis level will be downgraded to the lowest,“attention,” of the four-tier crisis alert system next month, the government said.The Korea Disease Control and Preventio...
Kwak Sung-sun
2024-04-19 3:27 PM
-
Policy
Seoul accepts university heads’ demand to lower medical school enrollment increase target
Prime Minister Han Duk-soo announced on Friday that the government would accept the request from six national university chiefs to reduce the targeted number of medical school stud...
Kim Yoon-mi
2024-04-19 3:56 PM
-
Device/ICT
Korea approves 2 more DTx for vision improvement, respiratory rehabilitation
The Ministry of Food and Drug Safety has granted approval to two more digital therapeutic (DTx) devices, developed by Nunaps and Share&Service. These devices, which are the third a...
Lee Han-soo
2024-04-19 1:01 PM
-
Hospital
Korean professor named associate editor of European Journal of Preventive Cardiology
Professor Jung Mi-hyang of the Department of Cardiology at the Catholic University of Korea St. Mary's Hospital was recently appointed associate editor of the European Journal of P...
Kim Chan-hyuk
2024-04-19 4:35 PM
-
Pharma
Secretive drug price negotiations on Lorviqua torture patients
The drug price negotiations for Pfizer's third-generation ALK-positive lung cancer drug Lorviqua (lorlatinib) are being done in excessive secrecy, leading to growing frustration am...
Kim Yun-mi
2024-04-19 1:18 PM
-
Pharma
Bridge Biotherapeutics advised to continue P2 study for idiopathic pulmonary fibrosis...
Bridge Biotherapeutics, a Korean biotech firm, announced positive feedback from the third Independent Data Monitoring Committee (IDMC) meeting to continue the phase 2 clinical tria...
Lee Han-soo
2024-04-19 2:01 PM
-
Hospital
Kidney cancer patient group leaders from 21 countries raise awareness and share...
The International Kidney Cancer Coalition (IKCC)’s International Conference 2024 wrapped up its three-day event in Incheon, Korea, on Tuesday. About 60 kidney cancer patient group ...
You Ji-young
2024-04-19 11:12 AM